High serum uric acid and low-grade inflammation are associated with smaller LDL and HDL particles

Atherosclerosis

Volumn 203, Issue 1, 2009, Pages 236-242

  Vekic, Jelena ^a   Jelic Ivanovic, Zorana ^a   Spasojevic Kalimanovska, Vesna ^a   Memon, Lidija ^b   Zeljkovic, Aleksandra ^a   Bogavac Stanojevic, Natasa ^a   Spasic, Slavica ^a  

^a Faculty of Pharmacy   (Serbia)

^b University Medical Center Bezanijska Kosa   (Serbia)

Author keywords

HDL size; hsCRP; Inflammation; Small, dense LDL; Uric acid

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; ISOELECTRIC FOCUSING; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR; URIC ACID BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PARTICLE SIZE; REGRESSION ANALYSIS; RISK FACTORS; URIC ACID;

EID: 60749105826     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.05.047     Document Type: Article

References (35)

1. Viazzi F., Leoncini G., Ratto E., and Pontremoli R. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived. J Clin Hypertens 8 (2006) 510-518
2. Jelic-Ivanovic Z., Memon L., Spasojevic-Kalimanovska V., Bogavac-Stanojevic N., and Spasic S. Independent association of high serum uric acid concentration with angiographically defined coronary artery disease. Tohoku J Exp Med 211 (2007) 369-377
3. Bonora E., Targher G., Zenere M.B., et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 20 (1996) 975-980
4. Johnson R., Segal M., Srinivas T., et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenic link?. J Am Soc Nephrol 16 (2005) 1909-1919
5. Coutinho T.A., Turner S.T., Peyser P.A., et al. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20 (2007) 83-89
6. Roos R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
7. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169 (2003) 203-214
8. Memon L., Spasojevic-Kalimanovska V., Bogavac-Stanojevic N., et al. Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease. Tohoku J Exp Med 209 (2006) 197-206
9. Vekic J., Topic A., Zeljkovic A., Jelic-Ivanovic Z., and Spasojevic-Kalimanovska V. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 40 (2007) 310-316
10. Zeljkovic A, Spasojevic-Kalimanovska V, Vekic J. et al. Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk? Clin Exp Med 2008; doi:10.1007/s10238-008-0165-z.
11. Rifai N., and Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47 (2001) 403-411
12. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
13. Rainwater D.L., Moore P.H., Shelledy W.R., and Dyer T.D. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res 38 (1997) 1261-1266
14. Bland J.M., and Altman D.G. Statistical notes: transformations, means and confidence intervals. BMJ 312 (1996) 1079
15. Yoo T.W., Sung K.C., Shin H.S., et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69 (2005) 928-933
16. Rho Y.H., Woo J.H., Choi S.J., et al. Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. Metab Clin Exp 57 (2008) 71-76
17. Bjornheden T., Babyi A., Bondjers G., and Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 123 (1996) 43-56
18. Ohashi R., Mu H., Wang X., Yao Q., and Chen C. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Q J Med 98 (2005) 845-856
19. Milionis H.J., and Elisaf M.S. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories. Curr Med Res Opin 16 (2000) 164-170
20. Naknishi N., Suzuki K., Kawashimo H., et al. Serum uric acid: correlation with biological, clinical and behavioral factors in Japanese men. J Epidemiol 9 (1999) 99-106
21. Barter P.J., Nicholls S., Rye K.A., et al. Antiinflammatory properties of HDL. Circ Res 95 (2004) 764-772
22. Puig J.G., and Ruilope L.M. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 17 (1999) 869-872
23. Schlotte V., Sevanian A., Hochstein P., and Weithmann K.U. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Rad Biol Med 25 (1998) 839-847
24. Vekic J., Kotur-Stevuljevic J., Jelic-Ivanovic Z., et al. Association of oxidative stress and PON1 with LDL and HDL size in middle-aged subjects. Eur J Clin Invest 37 (2007) 715-723
25. Sevanian A., Davies K.J.A., and Hochstein P. Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr 54 (1991) 1129S-1134S
26. Kanellis J., Watanabe S., Li J.H., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41 (2003) 1287-1293
27. Kanellis J., and Kang D.H. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 25 (2005) 39-42
28. Kotur-Stevuljevic J., Memon L., Stefanovic A., et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 40 (2007) 181-187
29. Zeller J.M., and Sullivan B.L. C-reactive protein selectively enhances the intracellular generation of reactive oxygen products by IgG-stimulated monocytes and neutrophils. J Leukocyte Biol 52 (1992) 449-455
30. Mertens A., and Hobvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J 15 (2001) 2073-2084
31. Allender S., Scarborough P., Peto V., et al. European cardiovascular disease statistics 2008 (2008), European Heart Network, Brussels, Belgium
32. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
33. Knezevic T. Health statistical yearbook of Republic of Serbia. 2006 (2007), Institute of public health of Serbia, Belgrade, Serbia p. 255-272
34. Erdogan D., Gullu H., Caliskan M., et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 59 (2005) 1276-1282
35. Ishizaka N., Ishizaka Y., Toda E.I., et al. Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 192 (2007) 131-137